Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1993)
Effect of immunosuppression with anti - T - cell monoclonal antibodies on the survival of organ cultured fetal pig xenografts in NOD mice
Islet isolation from the fetal pancreas
Charlton Charlton, Bacelj Bacelj, Slatery Slatery, Mandel Mandel (1989)
Cyclophosphamide induced diabetes mellitus in NOD/Wehi mice: Evidence for suppression in spontaneous autoimmune diabetesDiabetes, 38
D. Lenschow, Y. Zeng, Thistlethwaite, A. Montag, W. Brady, M. Gibson, P. Linsley, J. Bluestone (1992)
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.Science, 257 5071
B. Charlton, A. Bacelj, R. Slattery, T. Mandel (1989)
Cyclophosphamide-Induced Diabetes in NOD/WEHI Mice: Evidence for Suppression in Spontaneous Autoimmune Diabetes MellitusDiabetes, 38
T. Mandel, M. Koulmanda (1990)
The effect of continuous anti-CD4 monoclonal antibody therapy on fetal pig pancreas xenografts in nonobese diabetic mice.Transplantation proceedings, 22 5
T. Mandel, H. Dillon, M. Koulmanda (1995)
The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.Transplant immunology, 3 3
Mandel Mandel, Koulmanda Koulmanda, Bacelj Bacelj (1990)
Fetal pancreas transplantation in non‐obese diabetic (NOD) mice: A comparison of iso‐, allo‐ and xenograftsHorn Res Suppl, 25
T. Mandel, M. Koulmanda (1992)
Anti-CD3 monoclonal antibody prolongs survival of fetal pig pancreas grafts in NOD mice.Transplantation proceedings, 24 5
M. Koulmanda, T. Mandel (1993)
Rejection and histopathology of renal subcapsular fetal pig pancreas xenografts in normal and anti-CD4 monoclonal antibody-treated nonobese diabetic mice.Transplantation proceedings, 25 5
L. Grochow, M. Colvin (1979)
Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 4
T. Mandel, J. Kovarik, M. Koulmanda (1995)
A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice.The American journal of pathology, 147 3
T. Mandel, M. Koulmanda (1993)
Anti-T cell monoclonal antibodies for immunosuppression in xenotransplantation of fetal pig pancreas in NOD mice.Transplantation proceedings, 25 1 Pt 1
(1988)
rat antibody against a structure functionally related to the mouse
C. Simeonovic, R. Ceredig, J. Wilson (1990)
Effect of GK1.5 monoclonal antibody dosage on survival of pig proislet xenografts in CD4+ T cell-depleted mice.Transplantation, 49 5
clophosphamide induced
First Mr (1992)
Transplantation in the nineties.Transplantation, 53
Yan Wu, Yong Guo, Yang Liu (1993)
A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7The Journal of Experimental Medicine, 178
T. Mandel, M. Koulmanda, A. Bacelj (1990)
Fetal pancreas transplantation in non-obese diabetic (NOD) mice. A comparison of iso-, allo- and xenografts.Hormone and metabolic research. Supplement series, 25
T. Starzl, J. Fung, A. Tzakis, S. Todo, A. Demetris, I. Marino, H. Doyle, A. Zeevi, V. Warty, S. Kusne, W. Rudert, M. Trucco, M. Michaels (1993)
Baboon-to-human liver transplantationThe Lancet, 341
D. Dialynas, Z. Quan, K. Wall, A. Pierrès, J. Quintáns, M. Loken, M. Pierres, F. Fitch (1983)
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.Journal of immunology, 131 5
R. Evans (1990)
The actual and potential supply of organ donors in the United States.Clinical transplants
Abstract: Fetal pig islets, xenografted after organ culture into non‐immunosuppressed prediabetic NOD mice, are rejected within 10 days. Immunosuppression with anti‐T cell (anti‐CD4 and anti‐CD3) monoclonal antibodies alone is highly effective in delaying graft rejection in this discordant model, but rejection eventually occurs, usually within 80 days, despite marked depletion of T cells. In an attempt to prevent rejection, we used cyclophosphamide (CP), a powerful anti‐B cell agent, or CTL4Ig, an inhibitor of T‐cell co‐stimulation (via B7–1 (CD80) and B7–2 (CD86)), either given in combination with anti‐CD4 (GK1.5) or anti‐CD3 (KT3) MAb to the recipient mice. The addition of cyclophosphamide in a dose that significantly depleted B cells in peripheral blood was highly effective in preventing rejection, with xenografts surviving for at least 112 days, when the experiment was terminated. CTLA4Ig, administered alone, did not prevent delayed rejection (rejection occurred in <60 days) and, in contrast to CP, did not prevent delayed rejection when used in combination with GK1.5 and KT3 treatment. Thus, immunosuppressive agents found to be highly effective in other strains, e.g., CTLA4Ig and anti‐T cell MAbs, had a lesser effect in NOD mice but the addition of an anti‐B cell drug, CP, was useful. This finding may be applicable to patients with IDDM.
Xenotransplantation – Wiley
Published: Aug 1, 1998
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.